Celldex Therapeutics, Inc. Logo

Email this page: News Release

Oncothyreon and Celldex Therapeutics Announce Initiation of Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab

 

Separate multiple addresses with commas. Maximum 200 characters.
 
 


These email addresses will be used to email the page on your behalf and will not be used by Celldex Therapeutics, Inc. for any marketing purposes.

Send:       


 
This helps Celldex Therapeutics, Inc. prevent automated submissions.